ARCHIVES

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009

New Community Control Program May Be Developed

October 24, 1975

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989

On Biomedical Malthusianism; Varmus, et al. Propose a Strategy For Saving Biomedical Research

May 2, 2014

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010